Real World Data on the Efficacy and Safety of Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma. Data collected from the Colombian Hematology Centers

Authors :: Guillermo León-Basantes
Leonardo Bohorquez
Diana Otero-de la Hoz
Virginia Abello
Mónica Arévalo-Zambrano
Oliver Perilla
Cristina Acon-Solano
Bonell Patiño-Escobar
Karen Contreras
Luis Salazar-Montaña
Angela Peña-Castellanos
Luisana Molina
Mónica Osuna
Humberto Martínez-Cordero
Carlos Bermudez
Kenny Galvez
Claudia Sossa
Paola Guerrero
Guillermo Quintero
Jair Figueroa
Paola Omaña
Leonardo Enciso-Olivera
Paola Spirko
Jaiver Fonseca
Source :: Clinical Lymphoma Myeloma and Leukemia. 19:S317-S318
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Hematology
business.industry
medicine.disease
chemistry.chemical_compound
chemistry
Internal medicine
Ibrutinib
Relapsed refractory
Medicine
Mantle cell lymphoma
business
Real world data

Full Text Access

Tools